Christopher Guiffre

President chez Auron Therapeutics, Inc.

Profil

Mr. Christopher D.
Guiffre is a President & Chief Operating Officer at Auron Therapeutics, Inc., a Chief Financial & Operating Officer at Pear Therapeutics (US), Inc. and a Member at Massachusetts Bar Association.
Mr. Guiffre was previously employed as a Chief Executive Officer by Daré Bioscience, Inc., a President, Chief Executive Officer & Director by Cerulean Pharma, Inc., a President & Chief Executive Officer by Mercator Therapeutics, Inc., a Secretary, Senior Vice President & General Counsel by Cubist Pharmaceuticals, Inc., a VP, General Counsel & Director-Legal Affairs by Renaissance Worldwide, Inc., a President & Chief Executive Officer by Alvos Therapeutics, Inc., an Associate by BMC Partners LLP, a Chief Business Officer by Hydra Biosciences, Inc., an Associate by Morgan, Lewis & Bockius LLP, and a Chief Executive Officer by Pear Therapeutics, Inc. He received his undergraduate degree from Babson College, a graduate degree from Boston College Law School and an MBA from Wallace E Carroll School of Management.

Postes actifs de Christopher Guiffre

Sociétés	Poste	Début
Massachusetts Bar Association	Corporate Officer/Principal	-
Pear Therapeutics (US), Inc.	Directeur Financier/CFO	01/12/2017
Auron Therapeutics, Inc.	President	10/08/2023

Anciens postes connus de Christopher Guiffre

Sociétés	Poste	Fin
DARÉ BIOSCIENCE, INC.	Directeur Général	01/07/2017
Mercator Therapeutics, Inc.	Fondateur	11/04/2012
CUBIST PHARMACEUTICALS INC	Conseiller Juridique Général	30/04/2008
Renaissance Worldwide, Inc.	Conseiller Juridique Général	01/01/2001
Morgan, Lewis & Bockius LLP	Corporate Officer/Principal	-